Key result
Walking distance test effectively tracks functional gains after cardiac rehabilitation in ischemic heart disease.
Why the study?
Despite being a simple and reproducible test of exercise capacity, the use of the 6-minute walk test in patients with ischemic heart disease is less well accepted.
Does the 6-minute walk test accurately measure functional capacity, treatment response, and prognosis in patients with ischemic heart disease?
Systematic Review
Does the 6-minute walk test accurately measure functional capacity, treatment response, and prognosis in patients with ischemic heart disease?
The 6-minute walk test is a practical, well-validated tool for assessing functional capacity during cardiac rehabilitation in ischemic heart disease, but its prognostic utility following specific revascularization procedures requires further study.
Answers are grounded in this paper and cite their sources.
Supports 6-minute walk test monitoring during cardiac rehabilitation in ischemic heart disease; reinforces its utility while highlighting data gaps after revascularization.
Introduction: The 6-minute walk test (6MWT) has been used for over 30 years to assess exercise capacity in patients with respiratory disease, and more recently, in those with heart failure. However, despite being a simple and reproducible test of real-world exercise capacity, its use in patients with ischemic heart disease (IHD) is less well accepted. We sought to review systematically the evidence surrounding the 6MWT in IHD. Methods: nalysis (PRISMA) guidelines to select publications for full-text review and analyzed the collated data. Results: A total of 1228 unique papers were found, of which 71 were chosen for full-text review and 37 for detailed analysis. Most (23) concerned the effect on 6MWT distance (6MWTd) of cardiac rehabilitation, with measurements commenced after an intervention (acute myocardial infarction, n = 4; open heart surgery (OHS), n = 5; percutaneous coronary intervention (PCI), n = 3; or other, n = 11). The effect on 6MWTd of OHS was investigated in 6 studies and of PCI in one study. The 6MWT is a useful measurement of physical capacity; data are limited on its ability to assess benefit following PCI. Conclusions: The 6MWT has been studied inconsistently in IHD. The majority of data are on patients before and after CR. Data are limited concerning the effect on 6MWTd of OHS or PCI. The available data support the 6MWT as a measure of change in performance status following coronary intervention. More work is required to confirm this hypothesis.
No takes yet. Share an insight, caveat, or question.
Coulshed et al. (2023) conducted a systematic review in Ischemic Heart Disease (IHD). 6-Minute Walk Test (6MWT) was evaluated on Change in 6-minute walk test distance (6MWTd) following interventions or correlation with prognosis. The walking distance test is a useful measure of physical capacity and reflects performance changes following cardiac rehabilitation in ischemic heart disease, though data post-revascularization remain limited.
Synapse has enriched 10 related papers. Consider them for comparative context: